NY Times

One and Done: Why People Are Eager for Johnson & Johnson’s Vaccine

Johnson & Johnson’s one-shot vaccine is allowing states to rethink distribution, even as health officials and experts worry some will view it as inferior.

Continue

About the author

Darlene

Leave a Comment